FDA Has “Ample Regulatory Authority” To Oversee Cosmetics – McNeil
This article was originally published in The Rose Sheet
Executive Summary
FDA has "ample regulatory authority" to take action against cosmetic manufacturers who cross the line into making illegal drug claims, and should not resort to changing the regulatory status of certain categories of products, McNeil Personal Products Company states in comments to the agency
You may also be interested in...
AHA, BHA Products Are Cosmetics Based On Legal Precedent – CTFA
FDA should not address cosmetic compliance issues by reclassifying entire categories of products as drugs, the Cosmetic, Toiletry and Fragrance Association asserts in comments to the agency
Are Wrinkle Treatments With AHAs, BHAs OTCs? FDA Issues Call For Data
FDA is requesting information on the possible physiological effects of alpha hydroxy and beta hydroxy acids in wrinkle removers to help evaluate their regulatory status, according to a Dec. 31 Federal Register notice
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program